AAB-003

PF-05236812 · Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AAB-003, covering 2017-02-23 to 2017-02-23. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating The Safety Of AAB-003 (PF-05236812) In Subjects With Alzheimer's Disease [Phase 1]